249 related articles for article (PubMed ID: 28634830)
1. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
Hessam S; Sand M; Skrygan M; Bechara FG
Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
[TBL] [Abstract][Full Text] [Related]
2. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
[TBL] [Abstract][Full Text] [Related]
3. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.
Sand M; Skrygan M; Georgas D; Arenz C; Gambichler T; Sand D; Altmeyer P; Bechara FG
Mol Carcinog; 2012 Nov; 51(11):916-22. PubMed ID: 22025453
[TBL] [Abstract][Full Text] [Related]
5. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
[TBL] [Abstract][Full Text] [Related]
6. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
[TBL] [Abstract][Full Text] [Related]
7. Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background.
Hessam S; Sand M; Lang K; Käfferlein HU; Scholl L; Gambichler T; Skrygan M; Brüning T; Stockfleth E; Bechara FG
Dermatology; 2017; 233(2-3):129-135. PubMed ID: 28750404
[TBL] [Abstract][Full Text] [Related]
8. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs in Hidradenitis Suppurativa.
De Felice B; Montanino C; Mallardo M; Babino G; Mattera E; Ragozzino G; Argenziano G; Daniele A; Nigro E
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140712
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
[TBL] [Abstract][Full Text] [Related]
11. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.
Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC
Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403
[TBL] [Abstract][Full Text] [Related]
12. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
[TBL] [Abstract][Full Text] [Related]
13. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
[TBL] [Abstract][Full Text] [Related]
15. The role of PACT in the RNA silencing pathway.
Lee Y; Hur I; Park SY; Kim YK; Suh MR; Kim VN
EMBO J; 2006 Feb; 25(3):522-32. PubMed ID: 16424907
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa.
Guenin-Macé L; Morel JD; Doisne JM; Schiavo A; Boulet L; Mayau V; Goncalves P; Duchatelet S; Hovnanian A; Bondet V; Duffy D; Ungeheuer MN; Delage M; Nassif A; Di Santo JP; Demangel C
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32970636
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
[TBL] [Abstract][Full Text] [Related]
18. MCPIP1/Regnase-1 Expression in Keratinocytes of Patients with Hidradenitis Suppurativa: Preliminary Results.
Krajewski PK; Szukała W; Lichawska-Cieślar A; Matusiak Ł; Jura J; Szepietowski JC
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298861
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
[TBL] [Abstract][Full Text] [Related]
20. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
